PYC pyc therapeutics limited

new technical presentation, page-6

  1. 35,790 Posts.
    lightbulb Created with Sketch. 555
    An THIS while sure it's not peptide based but regardless ArmaGen Technologies raised $17M start-up financing from Boehringer Ingelheim, Shire & Takeda to advance their technology of slipping proteins via a trojan horse through the blood brain barrier. Yes maybe the milestones aren't as large as phylogicas ? who knows but the point i guess is PYC struggles for cash & to close deals aswell as amping up the BBB in presentations yet is any conglomerate of big pharma jumping up & throwing $17M around to find out ? Hell no - deals with upfronts at less than 10% of that value are taking years to close.

    Not really whinging, but, you get the idea.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.42
Change
-0.025(1.73%)
Mkt cap ! $850.1M
Open High Low Value Volume
$1.44 $1.47 $1.40 $364.7K 251.9K

Buyers (Bids)

No. Vol. Price($)
6 7552 $1.42
 

Sellers (Offers)

Price($) Vol. No.
$1.44 1414 1
View Market Depth
Last trade - 15.20pm 10/07/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.